NEW YORK (GenomeWeb News) - Nanogen on June 30 issued 2.9 million shares of its common stock to Amplimedical upon conversion of a promissory note issued to that company, whose diagnostics division Nanogen acquired in the spring, according to documents filed with the Securities and Exchange Commission today.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.